Episurf Medical received its first Notice of Allowance from The Canadian Intellectual Property Office, entitled “Surgical kit for cartilage repair comprising implant and a set of tools,” with a focus on the company’s Episealer® Femoral Twin implant and its design, commonly applied in cases of elongated cartilage lesions.
Episealer technology pairs an implant with a proprietary set of surgical instruments and a damage marking report for surgical pre-planning.
Further, the company was granted an additional patent in Australia, entitled “Method and node for manufacturing a surgical kit for cartilage repair.” This addresses Episurf’s 3D-based assessment of joint lesions.
Source: Episurf Medical AB Canada Patent; Australia Patent